Mechanism of action of GLP-1 receptor agonists: Direct receptor binding These medications bind specifically to GLP-1 receptors on pancreatic beta cells, stimulating insulin secretion in a glucose-dependent manner (meaning they work when blood glucose is elevated)
When balanced properly, this process effectively mobilizes stored reserves to promote weight loss
They can lower the risk of major cardiovascular events such as heart attack , stroke , and cardiovascular death, especially in individuals with type 2 diabetes who are at higher risk for these conditions
Complementary Research Compounds for Broader Metabolic Research Design Retatrutide's triple-agonist mechanism engages GLP-1, GIP, and glucagon receptors, but the broader biology of metabolic dysfunction extends beyond the receptors Retatrutide directly activates
For the side effect phenotypes, we defined separate casecontrol phenotypes for each side effect recorded in the survey, contrasting those who self-rated their side effects as moderate or severe (cases) to those who self-rated their side effects as mild or non-existent (controls)